Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
- PMID: 23103770
- DOI: 10.1016/j.bbcan.2012.10.002
Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is one of the most lethal malignancies, and is also the fourth most common cancer worldwide with around 700,000 new cases each year. Currently, first line chemotherapeutic drugs used for HCC include fluorouracil, cisplatin, doxorubicin, paclitaxel and mitomycin, but most of these are non-selective cytotoxic molecules with significant side effects. Sorafenib is the only approved targeted therapy by the U.S. Food and Drug Administration for HCC treatment, but patients suffer from various kinds of adverse effects, including hypertension. The signal-transducer-and-activator-of-transcription 3 (STAT3) protein, one of the members of STATs transcription factor family, has been implicated in signal transduction by different cytokines, growth factors and oncogenes. In normal cells, STAT3 activation is tightly controlled to prevent dysregulated gene transcription, whereas constitutively activated STAT3 plays an important role in tumorigenesis through the upregulation of genes involved in anti-apoptosis, proliferation and angiogenesis. Thus, pharmacologically safe and effective agents that can block STAT3 activation have the potential both for the prevention and treatment of HCC. In the present review, we discuss the possible role of STAT3 signaling cascade and its interacting partners in the initiation of HCC and also analyze the role of various STAT3 regulated genes in HCC progression, inflammation, survival, invasion and angiogenesis.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.Mol Oncol. 2015 Apr;9(4):818-33. doi: 10.1016/j.molonc.2014.12.008. Epub 2015 Jan 5. Mol Oncol. 2015. PMID: 25624051 Free PMC article.
-
Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.J Cell Physiol. 2012 May;227(5):2184-95. doi: 10.1002/jcp.22954. J Cell Physiol. 2012. PMID: 21792937
-
Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.Int J Mol Med. 2013 Jul;32(1):79-84. doi: 10.3892/ijmm.2013.1358. Epub 2013 Apr 22. Int J Mol Med. 2013. PMID: 23613111
-
Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.World J Gastroenterol. 2014 Nov 7;20(41):15269-74. doi: 10.3748/wjg.v20.i41.15269. World J Gastroenterol. 2014. PMID: 25386075 Free PMC article. Review.
-
[Review on the associations of signal transducer and activators of transcription 3 with hepatocellular carcinoma].Zhonghua Yu Fang Yi Xue Za Zhi. 2016 May;50(5):468-72. doi: 10.3760/cma.j.issn.0253-9624.2016.05.017. Zhonghua Yu Fang Yi Xue Za Zhi. 2016. PMID: 27141908 Review. Chinese.
Cited by
-
An integrated strategy of UPLC-Q-TOF-MS analysis, network pharmacology, and molecular docking to explore the chemical constituents and mechanism of Zixue Powder against febrile seizures.Heliyon. 2023 Dec 15;10(1):e23865. doi: 10.1016/j.heliyon.2023.e23865. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38192830 Free PMC article.
-
Recombinant leukemia inhibitory factor suppresses human medullary thyroid carcinoma cell line xenografts in mice.Cancer Lett. 2013 Oct 1;339(1):144-51. doi: 10.1016/j.canlet.2013.07.006. Epub 2013 Jul 12. Cancer Lett. 2013. PMID: 23856028 Free PMC article.
-
The multifaceted role of curcumin in cancer prevention and treatment.Molecules. 2015 Feb 5;20(2):2728-69. doi: 10.3390/molecules20022728. Molecules. 2015. PMID: 25665066 Free PMC article. Review.
-
The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes.PLoS One. 2015 Jul 30;10(7):e0134594. doi: 10.1371/journal.pone.0134594. eCollection 2015. PLoS One. 2015. PMID: 26226632 Free PMC article.
-
Red cell distribution width and inappropriateness of left ventricular mass in patients with untreated essential hypertension.PLoS One. 2015 Mar 20;10(3):e0120300. doi: 10.1371/journal.pone.0120300. eCollection 2015. PLoS One. 2015. PMID: 25793884 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous